feed,title,long_url,short_url
Benzinga,Global Monoclonal Antibodies (MABs) Market to Garner Around USD 450 Billion in 2031 and to Grow with a CAGR of ~14% During 2022-2031; Rising Incidence of Cancer to Steer Bright Market Growth,https://benzinga.com/pressreleases/22/08/g28533172/global-monoclonal-antibodies-mabs-market-to-garner-around-usd-450-billion-in-2031-and-to-grow-with,
